The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry
Open accessAbstract
Estrogen-induced progression through G1 phase of the cell cycle is preceded by increased expression of the G1-phase regulatory proteins c-Myc and cyclin D1. To investigate the potential contribution of these proteins to estrogen action, we derived clonal MCF-7 breast cancer cell lines in which c-Myc or cyclin D1 was expressed under the control of the metal-inducible metallothionein promoter. Inducible expression of either c-Myc or cyclin D1 was sufficient for S-phase entry in cells previously arrested in G1 phase by pretreatment with ICI 182780, a potent estrogen antagonist. c-Myc expression was not accompanied by increased cyclin D1 expression or Cdk4 activation, nor was cyclin D1 induction accompanied by increases in c-Myc. Expression of c-Myc or cyclin D1 was sufficient to activate cyclin E-Cdk2 by promoting the formation of high-molecular-weight complexes lacking the cyclin-dependent kinase inhibitor p21, as has been described, following estrogen treatment. Interestingly, this was accompanied by an association between active cyclin E-Cdk2 complexes and hyperphosphorylated p130, identifying a previously undefined role for p130 in estrogen action. These data provide evidence for distinct c-Myc and cyclin D1 pathways in estrogen-induced mitogenesis which converge on or prior to the formation of active cyclin E-Cdk2-p130 complexes and loss of inactive cyclin E-Cdk2-p21 complexes, indicating a physiologically relevant role for the cyclin E binding motifs shared by p130 and p21.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862 · cited 2×
“Hypophosphorylated pocket proteins bind and repress the transcriptional activity of the E2F/DP family of proteins, and phosphorylation of these pocket proteins by CDKs releases E2F/DP, with consequent activation of transcription of genes whose products are required for S-phase progression (46, 66).”
Morgan, D. O. (1995) · Nature · doi:10.1038/374131a0 · Cited by 3,284
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
Sherr, C. J. (1993) · Cell · doi:10.1016/0092-8674(93)90636-5 · Cited by 1,960
Meijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J., & Moulinoux, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00527.x · Cited by 1,352
Human Cyclin E, a Nuclear Protein Essential for the G1-to-S Phase Transition
Ohtsubo, M., Theodoras, A. M., Schumacher, J., Roberts, J. M., & Pagano, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2612 · Cited by 1,148
Distinct Roles for Cyclin-Dependent Kinases in Cell Cycle Control
van den Heuvel, S., & Harlow, E. (1993) · Science · doi:10.1126/science.8266103 · Cited by 1,092
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
Quelle, D. E., Ashmun, R. A., Shurtleff, S. A., Kato, J. Y., Bar-Sagi, D., Roussel, M. F., & Sherr, C. J. (1993) · Genes & Development · doi:10.1101/gad.7.8.1559 · Cited by 1,032
Cyclin D1 provides a link between development and oncogenesis in the retina and breast
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., & Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90034-9 · Cited by 1,021
Sherr, C. J. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89005-2 · Cited by 980
Resnitzky, D., Gossen, M., Bujard, H., & Reed, S. I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1669-1679.1994 · Cited by 965
Proteins of the Myc Network: Essential Regulators of Cell Growth and Differentiation
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60353-x · Cited by 779
De Azevedo, W. F., Leclerc, S., Meijer, L., Havlicek, L., Strnad, M., & Kim, S. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.0518a.x · Cited by 729
Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture.
Henderson, B. E., Ross, R. K., & Bernstein, L. (1988) · PubMed · Cited by 700
Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.
Fantl, V, Stamp, G., Andrews, A., Rosewell, I., & Dickson, C. (1995) · Genes & Development · doi:10.1101/gad.9.19.2364 · Cited by 691
Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15.
Gu, Y., Rosenblatt, J., & Morgan, D. O. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05493.x · Cited by 642
Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family
Koff, A., Cross, F., Fisher, A., Schumacher, J., Leguellec, K., Philippe, M., & Roberts, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90044-y · Cited by 642
Kitagawa, M., Higashi, H., Jung, H. K., Suzuki-Takahashi, I., Ikeda, M., Tamai, K., Kato, J., Segawa, K., Yoshida, E., Nishimura, S., et al. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01097.x · Cited by 589
Cyclins and cyclin-dependent kinases: a biochemical view
Pines, J. (1995) · Biochemical Journal · doi:10.1042/bj3080697 · Cited by 538
Prall, O. J., Sarcevic, B., Musgrove, E. A., Watts, C. W., & Sutherland, R. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10882 · Cited by 444
Self-citationMusgrove, E. A., Lee, C. S., Buckley, M. F., & Sutherland, R. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8022 · Cited by 376
Self-citationAdams, P. D., Sellers, W. R., Sharma, S. K., Wu, A. D., Nalin, C. M., & Kaelin, W. G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6623 · Cited by 373
Altucci, L., Addeo, R., Cicatiello, L., Dauvois, S., Parker, M., Truss, M., Beato, M., Sica, V., Bresciani, F., & Weisz, A. (1996) · PubMed · Cited by 343
Li, Y., Graham, C., Lacy, S., Duncan, A. M., & Whyte, P. (1993) · Genes & Development · doi:10.1101/gad.7.12a.2366 · Cited by 337
Cell cycle-specific association of E2F with the p130 E1A-binding protein.
Cobrinik, D., Whyte, P., Peeper, D. S., Jacks, T., & Weinberg, R. A. (1993) · Genes & Development · doi:10.1101/gad.7.12a.2392 · Cited by 335
Oestrogen-responsive human breast cancer in long term tissue culture
LIPPMAN, M. E., & BOLAN, G. (1975) · Nature · doi:10.1038/256592a0 · Cited by 335
E2F-4 Switches from p130 to p107 and pRB in Response to Cell Cycle Reentry
Moberg, K., Starz, M. A., & Lees, J. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1436 · Cited by 328
Lukas, J., Bartkova, J., & Bartek, J. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.6917 · Cited by 327
Differential modulation of cyclin gene expression by MYC.
Jansen-Dürr, P., Meichle, A., Steiner, P., Pagano, M., Finke, K., Botz, J., Wessbecher, J., Draetta, G., & Eilers, M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3685 · Cited by 314
Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
Vlach, J., Hennecke, S., Alevizopoulos, K., Conti, D., & Amati, B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01050.x · Cited by 313
The cdk2 kinase is required for the G1-to-S transition in mammalian cells.
Tsai, L., Lees, E. M., Faha, B., Harlow, E. E., & Riabowol, K. T. (1993) · PubMed · Cited by 310
Vairo, G., Livingston, D. M., & Ginsberg, D. (1995) · Genes & Development · doi:10.1101/gad.9.7.869 · Cited by 293
Sutherland, R. L., Hall, R. E., & Taylor, I. W. (1983) · PubMed · Cited by 285
Self-citationDubik, D., Dembinski, T. C., & Shiu, R. P. C. (1987) · PubMed · Cited by 276
Estrogen-Dependent Cyclin E-cdk2 Activation through p21 Redistribution
Planas-Silva, M. D., & Weinberg, R. A. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4059 · Cited by 267
Repression of cyclin D1: a novel function of MYC.
Philipp, A., Schneider, A., Väsrik, I., Finke, K., Xiong, Y., Beach, D., Alitalo, K., & Eilers, M. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.4032 · Cited by 251
Identification of a Myc-dependent step during the formation of active G1 cyclin-cdk complexes.
Steiner, P., Philipp, A., Lukas, J., Godden-Kent, D., Pagano, M., Mittnacht, S., Bartek, J., & Eilers, M. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00163.x · Cited by 246
Foster, J. S. (1996) · Molecular Endocrinology · doi:10.1210/me.10.5.488 · Cited by 244
Pérez-Roger, I., Solomon, D. L., Sewing, A., & Land, H. (1997) · Oncogene · doi:10.1038/sj.onc.1201197 · Cited by 230
Daksis, J. I., Lu, R. Y., Facchini, L. M., Marhin, W. W., & Penn, L. Z. (1994) · PubMed · Cited by 227
Aprelikova, O., Xiong, Y., & Liu, E. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.31.18195 · Cited by 203
The Retinoblastoma Protein: More than a Tumor Suppressor
Riley, D. J., Lee, E. Y.-H. P., & Lee, W.-H. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.000245 · Cited by 202
Watts, C. K. (1995) · Molecular Endocrinology · doi:10.1210/me.9.12.1804 · Cited by 185
Self-citationEstrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice
Soule, H. D., & McGrath, C. M. (1980) · Cancer Letters · doi:10.1016/0304-3835(80)90042-7 · Cited by 178
Watson, P. H., Pon, R. T., & Shiu, R. P. C. (1991) · PubMed · Cited by 177
Activation of cyclin‐dependent kinases by Myc mediates induction of cyclin A, but not apoptosis.
Rudolph, B., Saffrich, R., Zwicker, J., Henglein, B., Müller, R., Ansorge, W. J., & Eilers, M. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00669.x · Cited by 144
Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130.
Mayol, X., Garriga, J., & Graña, X. (1995) · PubMed · Cited by 143
Estrogen Induction of N-myc and c-myc Proto-Oncogene Expression in The Rat Uterus*
Murphy, L. J., Murphy, L. C., & Friesen, H. G. (1987) · Endocrinology · doi:10.1210/endo-120-5-1882 · Cited by 133
Wilcken, N. R. C., Prall, O. W. J., Musgrove, E. A., & Sutherland, R. L. (1997) · PubMed · Cited by 118
Self-citationp130 and p107 Use a Conserved Domain To Inhibit Cellular Cyclin-Dependent Kinase Activity†
Woo, M. S., Sánchez, I., & Dynlacht, B. D. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.3566 · Cited by 114
Rescue of defective mitogenic signaling by D-type cyclins.
Roussel, M. F., Theodoras, A. M., Pagano, M., & Sherr, C. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6837 · Cited by 111
Lack of relationship between CDK activity and G1 cyclin expression in breast cancer cells
Sweeney, K. J. E., Swarbrick, A., Sutherland, R. L., & Musgrove, E. A. (1998) · Oncogene · doi:10.1038/sj.onc.1201814 · Cited by 93
Self-citationA Unique Domain of pRb2/p130 Acts as an Inhibitor of Cdk2 Kinase Activity
Luca, A. D., MacLachlan, T. K., Bagella, L., Dean, C., Howard, C. M., Claudio, P. P., Baldi, A., Khalili, K., & Giordano, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.20971 · Cited by 90
p21 Disrupts the Interaction between cdk2 and the E2F-p130 Complex
Shiyanov, P. A., Bagchi, S., Adami, G. R., Kokontis, J. M., Hay, N., Arroyo, M., Morozov, A., & Raychaudhuri, P. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.737 · Cited by 88
Hermeking, H., Funk, J. O., Reichert, M., et al. (1995) · PubMed · Cited by 78
Mayol, X., Garriga, J., & Graña, X. (1996) · PubMed · Cited by 75
Haas, K., Staller, P., Geisen, C., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201171 · Cited by 74
Biological response to phorbol ester determined by alternative G1 pathways.
Huang, T., Duyster, J., & Wang, J. Y. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4793 · Cited by 60
Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases
Pusch, O., BERNASCHEK, G., Eilers, M., & Hengstschläger, M. (1997) · Oncogene · doi:10.1038/sj.onc.1201236 · Cited by 60
Daly, R. J., Harris, W. H., Wang, D. Y., & Darbre, P. D. (1991) · PubMed · Cited by 55
Leung, B. S., & Potter, A. H. (1987) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240340307 · Cited by 48
Expression of cyclin D1 mRNA is not upregulated by Myc in rat fibroblasts.
Solomon, D. L., Philipp, A., Land, H., & Eilers, M. (1995) · PubMed · Cited by 41
DeFazio, A., Chiew, Y.-E., McEvoy, M., Watts, C. K. W., & Sutherland, R. L. (1997) · PubMed · Cited by 41
Self-citationMusgrove, E. A., Šarčević, B., & Sutherland, R. L. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960301)60:3<363::aid-jcb8>3.0.co;2-u · Cited by 37
Self-citation
Cited by
The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D’Amico, M., Pestell, R., & Ben-Ze’ev, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5522 · Cited by 2,230
Biological determinants of endocrine resistance in breast cancer
Musgrove, E. A., & Sutherland, R. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2713 · Cited by 1,252
Self-citationSingle-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Chung, W., Eum, H. H., Lee, H.-O., Lee, K.-M., Lee, H.-B., Kim, K.-T., Ryu, H. S., Kim, S., Lee, J. E., Park, Y. H., et al. (2017) · Nature Communications · doi:10.1038/ncomms15081 · Cited by 992
“Most carcinoma cells in all luminal tumours (BC01, BC02 and BC03) expressed high levels of ER and the canonical ER pathway genes 20,33,34 (Fig.”
Overcoming Endocrine Resistance in Breast Cancer
Hanker, A. B., Sudhan, D. R., & Arteaga, C. L. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.009 · Cited by 927
Ström, A., Hartman, J., Foster, J. S., Kietz, S., Wimalasena, J., & Gustafsson, J.-Å. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308319100 · Cited by 534
Metadata
- Authors
- Prall, O. W. J., Rogan, E. M., Musgrove, E. A., Watts, C. K. W., & Sutherland, R. L.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 1998-08-01
- Volume
- 18
- Issue
- 8
- Pages
- 4499-4508
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2142095017
- Cited by
- 267
- References
- 65
- FWCI
- 8.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.